HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeong-Oh Kim Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

1/2021The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy.
11/2020A Highly Sensitive Next-Generation Sequencing-Based Genotyping Platform for EGFR Mutations in Plasma from Non-Small Cell Lung Cancer Patients.
11/2020Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma.
3/2019Prognostic role of beclin-1 in locally advanced non-small cell lung cancer in patients receiving docetaxel-platinum induction chemotherapy.
5/2016The prognostic role of tissue and serum MMP-1 and TIMP-1 expression in patients with non-small cell lung cancer.
1/2013Predictive efficacy of low burden EGFR mutation detected by next-generation sequencing on response to EGFR tyrosine kinase inhibitors in non-small-cell lung carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeong-Oh Kim Research Topics

Disease

9Neoplasms (Cancer)
01/2021 - 08/2010
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2013
4Lung Neoplasms (Lung Cancer)
10/2021 - 01/2013
2Neoplasm Metastasis (Metastasis)
01/2021 - 12/2020
2Stomach Neoplasms (Stomach Cancer)
12/2020 - 08/2010
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2020 - 05/2016
2Adenocarcinoma
05/2016 - 07/2013
1Hypoxia (Hypoxemia)
11/2020
1Necrosis
11/2020
1Anemia
07/2015
1Nausea
07/2015
1Neutropenia
07/2015
1Squamous Cell Carcinoma of Head and Neck
08/2013
1Oropharyngeal Neoplasms
08/2013
1Retinoblastoma (Glioblastoma, Retinal)
07/2013
1Adenocarcinoma of Lung
07/2013

Drug/Important Bio-Agent (IBA)

2ErbB Receptors (EGF Receptor)IBA
11/2020 - 01/2013
2Tyrosine Kinase InhibitorsIBA
11/2020 - 01/2013
2Proteins (Proteins, Gene)FDA Link
11/2020 - 09/2010
2Docetaxel (Taxotere)FDA Link
03/2019 - 07/2015
1Taxoids (Taxanes)IBA
10/2021
1rho GTPase-activating proteinIBA
12/2020
1Cadherins (E-Cadherin)IBA
12/2020
1Tight Junction ProteinsIBA
12/2020
1Protein Isoforms (Isoforms)IBA
12/2020
1Peptide Nucleic AcidsIBA
11/2020
1pimonidazoleIBA
11/2020
1N- (4- (3- (1H- 1,2,4- triazol- 1- yl)- 4- (3,4,5- trimethoxybenzoyl)phenyl)thiazol- 2- yl)- 2- amino- 3- methylbutanamideIBA
11/2020
1Eosine Yellowish-(YS) (Eosin)IBA
11/2020
1Hematoxylin (Haematoxylon)IBA
11/2020
1TubulinIBA
11/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020
1Beclin-1IBA
03/2019
1PlatinumIBA
03/2019
1KinesinsIBA
03/2018
1Tissue Inhibitor of Metalloproteinase-1IBA
05/2016
1Matrix Metalloproteinases (MMPs)IBA
05/2016
1InterferonsIBA
08/2013
1Cyclin-Dependent Kinases (cdk Proteins)IBA
07/2013
1CINK4IBA
07/2013
1Paclitaxel (Taxol)FDA LinkGeneric
07/2013
1Cyclin D1IBA
07/2013
1Pharmaceutical PreparationsIBA
09/2010
1Reduced Folate Carrier ProteinIBA
09/2010
1Messenger RNA (mRNA)IBA
09/2010
1Methotrexate (Mexate)FDA LinkGeneric
09/2010
1Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA
09/2010
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
08/2010
1Membrane Proteins (Integral Membrane Proteins)IBA
08/2010
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
08/2010
1Fluorouracil (Carac)FDA LinkGeneric
08/2010

Therapy/Procedure

2Therapeutics
01/2021 - 03/2019
1Time-to-Treatment
01/2021
1Immunotherapy
01/2021
1Aftercare (After-Treatment)
11/2020
1Radiotherapy
11/2020
1Induction Chemotherapy
03/2019
1Drug Therapy (Chemotherapy)
08/2013